{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T04:39:45Z","timestamp":1793162385952,"version":"4.5.0"},"reference-count":60,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T00:00:00Z","timestamp":1748649600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Caroline Sirois"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To summarize knowledge on medications and medication-disinfection byproducts\u2014compounds formed when pharmaceutical contaminants react with disinfectants\u2014found in drinking water and its sources (effluents, surface water, groundwater), aiming to raise awareness and empower pharmacists to implement best practices for improving public health and reducing environmental impact.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A scoping review was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews. Data were retrieved from Medline and Embase between 2005 and 2023 using keywords related to drinking water, pharmaceutical waste, and water purification. Articles had to focus on human medication use and originate from North America and Europe. Data on types of medications, concentrations found in drinking water or its sources, and types of byproducts were extracted, and a narrative synthesis was written.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key findings<\/jats:title>\n                    <jats:p>Forty-five articles were included. Among pre-defined classes, antihypertensives, analgesics, antibiotics, and psychotropic medications were most frequently found. The most commonly identified medications included carbamazepine, diclofenac, ibuprofen, and acetaminophen\/paracetamol. Traces of medications were present in many water sources, with higher concentrations near pharmaceutical industries. Some medications, like carbamazepine, persist in the environment for extended periods. Although not necessarily found in drinking water, medication-disinfection byproducts can be toxic, and further evidence is required to assess their risk.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Many medications are found in drinking water and its sources, highlighting the need for pharmacists to consider their public health impact. Best practices, such as prescribing only when necessary, deprescribing, social\/green prescribing, and opting for environmentally friendly alternatives, should be enforced.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ijpp\/riaf038","type":"journal-article","created":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T07:48:07Z","timestamp":1746431287000},"page":"360-368","source":"Crossref","is-referenced-by-count":12,"title":["Pharmaceuticals in drinking water: a scoping review to raise pharmacists\u2019 public health and environmental awareness on contamination in groundwater, surface water, and other sources"],"prefix":"10.1093","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-8303-5388","authenticated-orcid":false,"given":"Mandy","family":"Coderre","sequence":"first","affiliation":[{"name":"Facult\u00e9 de pharmacie, Universit\u00e9 Laval , Qu\u00e9bec ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3336-2300","authenticated-orcid":false,"given":"Ann-Sophie","family":"Fortin","sequence":"additional","affiliation":[{"name":"Facult\u00e9 de pharmacie, Universit\u00e9 Laval , Qu\u00e9bec ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis-David","family":"Morency","sequence":"additional","affiliation":[{"name":"Facult\u00e9 de pharmacie, Universit\u00e9 Laval , Qu\u00e9bec ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2807-4008","authenticated-orcid":false,"given":"Juliette","family":"Roy","sequence":"additional","affiliation":[{"name":"Facult\u00e9 de pharmacie, Universit\u00e9 Laval , Qu\u00e9bec ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3294-7883","authenticated-orcid":false,"given":"Caroline","family":"Sirois","sequence":"additional","affiliation":[{"name":"Facult\u00e9 de pharmacie, Universit\u00e9 Laval , Qu\u00e9bec ,","place":["Canada"]},{"name":"Centre d\u2019excellence sur le vieillissement de Qu\u00e9bec, VITAM- Centre de recherche en sant\u00e9 durable , Qu\u00e9bec ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,5,31]]},"reference":[{"key":"2025072423370856900_CIT0001","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1016\/s0140-6736(18)30941-3","article-title":"Making more of multimorbidity: an emerging priority","volume":"391","author":"The","year":"2018","journal-title":"Lancet"},{"key":"2025072423370856900_CIT0002","first-page":"1","article-title":"Portrait de la polypharmacie chez les a\u00een\u00e9s qu\u00e9b\u00e9cois entre 2000 et 2016","volume":"34","author":"Gosselin","year":"2020","journal-title":"Institut national de sant\u00e9 publique du Qu\u00e9bec, Qu\u00e9bec; Gouvernement du Qu\u00e9bec"},{"key":"2025072423370856900_CIT0003","author":"Patented Medicine Prices Review Board","year":"2023"},{"key":"2025072423370856900_CIT0004","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1007\/s11270-013-1770-3","article-title":"A review of pharmaceuticals and endocrine-disrupting compounds: sources, effects, removal, and detections","volume":"224","author":"Tijani","year":"2013","journal-title":"Water, Air, Soil Pollution."},{"key":"2025072423370856900_CIT0005","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.envint.2009.10.003","article-title":"Environmental risk assessment of pharmaceuticals in rivers: relationships between hazard indexes and aquatic macroinvertebrate diversity indexes in the llobregat river (NE Spain)","volume":"36","author":"Ginebreda","year":"2010","journal-title":"Environ Int"},{"key":"2025072423370856900_CIT0006","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/nature02317","article-title":"Diclofenac residues as the cause of vulture population decline in Pakistan","volume":"427","author":"Oaks","year":"2004","journal-title":"Nature"},{"key":"2025072423370856900_CIT0007","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.aquatox.2004.01.002","article-title":"Comparative responses of molluscs and fish to environmental estrogens and an estrogenic effluent","volume":"66","author":"Jobling","year":"2004","journal-title":"Aquat Toxicol"},{"key":"2025072423370856900_CIT0008","doi-asserted-by":"publisher","first-page":"8897","DOI":"10.1073\/pnas.0609568104","article-title":"Collapse of a fish population after exposure to a synthetic estrogen","volume":"104","author":"Kidd","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"2025072423370856900_CIT0009","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.jhazmat.2014.07.029","article-title":"Transformation of pharmaceuticals during oxidation\/disinfection processes in drinking water treatment","volume":"279","author":"Postigo","year":"2014","journal-title":"J Hazard Mater"},{"key":"2025072423370856900_CIT0010","doi-asserted-by":"publisher","first-page":"127579","DOI":"10.1016\/j.chemosphere.2020.127579","article-title":"Detection, transformation, and toxicity of indole-derivative nonsteroidal anti-inflammatory drugs during chlorine disinfection","volume":"260","author":"Qiu","year":"2020","journal-title":"Chemosphere"},{"key":"2025072423370856900_CIT0011","author":"International Pharmaceutical Federation","year":"2023"},{"key":"2025072423370856900_CIT0012","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann Intern Med"},{"key":"2025072423370856900_CIT0013","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"Bmj"},{"key":"2025072423370856900_CIT0014","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.watres.2014.10.049","article-title":"A pilot study on the assessment of trace organic contaminants including pharmaceuticals and personal care products from on-site wastewater treatment systems along Skaneateles Lake in New York State, USA","volume":"72","author":"Subedi","year":"2015","journal-title":"Water Res"},{"key":"2025072423370856900_CIT0015","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.scitotenv.2016.12.004","article-title":"Nationwide reconnaissance of contaminants of emerging concern in source and treated drinking waters of the United States","volume":"581-582","author":"Glassmeyer","year":"2017","journal-title":"Sci Total Environ"},{"key":"2025072423370856900_CIT0016","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s10311-009-0253-7","article-title":"Occurence of pharmaceuticals and hormones in drinking water treated from surface waters","volume":"9","author":"Vulliet","year":"2011","journal-title":"Environ Chem Lett"},{"key":"2025072423370856900_CIT0017","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.scitotenv.2018.07.240","article-title":"Environmental loadings of active pharmaceutical ingredients from manufacturing facilities in Canada","volume":"646","author":"Kleywegt","year":"2019","journal-title":"Sci Total Environ"},{"key":"2025072423370856900_CIT0018","first-page":"40","article-title":"Pharmaceuticals in water cycle: a review on risk assessment and wastewater and sludge treatment","volume":"19","author":"Morosini","year":"2020","journal-title":"Emerging contaminants; risk assessment; sewage sludge; treatment options; wastewater"},{"key":"2025072423370856900_CIT0019","doi-asserted-by":"publisher","first-page":"134057","DOI":"10.1016\/j.scitotenv.2019.134057","article-title":"Occurrence, interactive effects and ecological risk of diclofenac in environmental compartments and biota - a review","volume":"698","author":"Sathishkumar","year":"2020","journal-title":"Sci Total Environ"},{"key":"2025072423370856900_CIT0020","doi-asserted-by":"publisher","first-page":"133","DOI":"10.17269\/s41997-021-00499-3","article-title":"Pharmaceuticals in source waters of 95 First Nations in Canada","volume":"112","author":"Schwartz","year":"2021","journal-title":"Can J Public Health"},{"key":"2025072423370856900_CIT0021","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.scitotenv.2014.10.021","article-title":"Occurrence and removal of transformation products of PPCPs and illicit drugs in wastewaters: a review","volume":"505","author":"Evgenidou","year":"2015","journal-title":"Sci Total Environ"},{"key":"2025072423370856900_CIT0022","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.scitotenv.2017.02.209","article-title":"Implementing ecopharmacovigilance (EPV) from a pharmacy perspective: a focus on non-steroidal anti-inflammatory drugs","volume":"603-604","author":"Wang","year":"2017","journal-title":"Sci Total Environ"},{"key":"2025072423370856900_CIT0023","doi-asserted-by":"publisher","first-page":"100927","DOI":"10.1016\/j.jwpe.2019.100927","article-title":"Occurrence, fate and removal of pharmaceutically active compounds (PhACs) in water and wastewater treatment plants\u2014a review","volume":"32","author":"Couto","year":"2019","journal-title":"J Water Process Eng"},{"key":"2025072423370856900_CIT0024","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1016\/j.scitotenv.2011.01.010","article-title":"Pharmaceuticals, hormones and bisphenol a in untreated source and finished drinking water in Ontario, Canada--occurrence and treatment efficiency","volume":"409","author":"Kleywegt","year":"2011","journal-title":"Sci Total Environ"},{"key":"2025072423370856900_CIT0025","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.envint.2008.10.008","article-title":"Occurence and fate of pharmaceutical products and by-products, from resource to drinking water","volume":"35","author":"Mompelat","year":"2009","journal-title":"Environ Int"},{"key":"2025072423370856900_CIT0026","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1080\/01919512.2013.793595","article-title":"A Survey of occurrence and risk assessment of pharmaceutical substances in the Great Lakes Basin","volume":"35","author":"Uslu","year":"2013","journal-title":"Ozone: Science Engineering"},{"key":"2025072423370856900_CIT0027","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.ecoleng.2016.06.093","article-title":"Comparison of the removal efficiencies of selected pharmaceuticals in wastewater treatment plants in the region of Murcia, Spain","volume":"95","author":"Fern\u00e1ndez-L\u00f3pez","year":"2016","journal-title":"Ecol Eng"},{"key":"2025072423370856900_CIT0028","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/j.chemosphere.2010.10.041","article-title":"Analysis of the presence of cardiovascular and analgesic\/anti-inflammatory\/antipyretic pharmaceuticals in river- and drinking-water of the Madrid Region in Spain","volume":"82","author":"Valc\u00e1rcel","year":"2011","journal-title":"Chemosphere"},{"key":"2025072423370856900_CIT0029","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.1002\/etc.5453","article-title":"The Prevalence of opioids in US drinking water sources detected using direct-injection high-performance liquid chromatography-tandem mass spectrometry","volume":"41","author":"Skaggs","year":"2022","journal-title":"Environ Toxicol Chem"},{"key":"2025072423370856900_CIT0030","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4419-6406-9_1","article-title":"Chemicals of emerging concern in the Great Lakes Basin: an analysis of environmental exposures","volume":"207","author":"Klecka","year":"2010","journal-title":"Rev Environ Contam Toxicol"},{"key":"2025072423370856900_CIT0031","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.scitotenv.2015.12.081","article-title":"Septic systems as sources of organic wastewater compounds in domestic drinking water wells in a shallow sand and gravel aquifer","volume":"547","author":"Schaider","year":"2016","journal-title":"Sci Total Environ"},{"key":"2025072423370856900_CIT0032","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.scitotenv.2013.08.067","article-title":"Pharmaceuticals, perfluorosurfactants, and other organic wastewater compounds in public drinking water wells in a shallow sand and gravel aquifer","volume":"468-469","author":"Schaider","year":"2014","journal-title":"Sci Total Environ"},{"key":"2025072423370856900_CIT0033","doi-asserted-by":"publisher","first-page":"3313","DOI":"10.1007\/s10311-022-01441-w","article-title":"Occurrence, fate, and risk of the organic pollutants of the surface water watch list in European groundwaters: a review","volume":"20","author":"Jurado","year":"2022","journal-title":"Environ Chem Lett"},{"key":"2025072423370856900_CIT0034","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/s0378-4274(02)00041-3","article-title":"Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: a review of recent research data","volume":"131","author":"Heberer","year":"2002","journal-title":"Toxicol Lett"},{"key":"2025072423370856900_CIT0035","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1016\/j.scitotenv.2016.03.128","article-title":"Nationwide reconnaissance of contaminants of emerging concern in source and treated drinking waters of the United States: Pharmaceuticals","volume":"579","author":"Furlong","year":"2017","journal-title":"Sci Total Environ"},{"key":"2025072423370856900_CIT0036","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.scitotenv.2008.04.028","article-title":"A national reconnaissance of pharmaceuticals and other organic wastewater contaminants in the United States--I) groundwater","volume":"402","author":"Barnes","year":"2008","journal-title":"Sci Total Environ"},{"key":"2025072423370856900_CIT0037","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/j.chemosphere.2009.09.021","article-title":"Psychiatric pharmaceuticals in the environment","volume":"77","author":"Calisto","year":"2009","journal-title":"Chemosphere"},{"key":"2025072423370856900_CIT0038","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.watres.2011.10.056","article-title":"Environmental occurrence, fate and transformation of benzodiazepines in water treatment","volume":"46","author":"Kosjek","year":"2012","journal-title":"Water Res"},{"key":"2025072423370856900_CIT0039","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1002\/etc.2351","article-title":"A multicomponent snapshot of pharmaceuticals and pesticides in the river Meuse basin","volume":"32","author":"Houtman","year":"2013","journal-title":"Environ Toxicol Chem"},{"key":"2025072423370856900_CIT0040","first-page":"181","article-title":"Environmental emission of pharmaceuticals from wastewater treatment plants in the USA","volume-title":"Persistent Organic Chemicals in the Environment: Status and trends in the Pacific Basin Countries","author":"Subedi","year":"2016"},{"key":"2025072423370856900_CIT0041","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.jhazmat.2005.03.007","article-title":"Contribution of effluents from hospitals and private households to the total loads of diclofenac and carbamazepine in municipal sewage effluents--modeling versus measurements","volume":"122","author":"Heberer","year":"2005","journal-title":"J Hazard Mater"},{"key":"2025072423370856900_CIT0042","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.scitotenv.2015.12.057","article-title":"The fate of organic micropollutants during long-term\/long-distance river bank filtration","volume":"545-546","author":"Hamann","year":"2016","journal-title":"Sci Total Environ"},{"key":"2025072423370856900_CIT0043","doi-asserted-by":"publisher","first-page":"26778","DOI":"10.1007\/s11356-017-0216-7","article-title":"Presence of active pharmaceutical ingredients in the continuum of surface and ground water used in drinking water production","volume":"24","author":"Ahkola","year":"2017","journal-title":"Environ Sci Pollut Res Int"},{"key":"2025072423370856900_CIT0044","doi-asserted-by":"publisher","first-page":"231","DOI":"10.2166\/wqrj.2007.026","article-title":"Pharmaceuticals in the Yamaska River, Quebec, Canada","volume":"42","author":"Yargeau","year":"2007","journal-title":"Water Qual. Res. J."},{"key":"2025072423370856900_CIT0045","doi-asserted-by":"publisher","first-page":"172816","DOI":"10.1016\/j.ejphar.2019.172816","article-title":"Cytostatic pharmaceuticals as water contaminants","volume":"866","author":"Jureczko","year":"2020","journal-title":"Eur J Pharmacol"},{"key":"2025072423370856900_CIT0046","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1684\/ers.2017.1075","article-title":"Review of wastewater, surface water and groundwater contamination by pharmaceuticals","volume":"17","author":"Togola","year":"2018","journal-title":"Environ Risque Sante"},{"key":"2025072423370856900_CIT0047","doi-asserted-by":"publisher","DOI":"10.1787\/c936f42d-en","volume-title":"Pharmaceutical Residues in Freshwater: Hazards and Policy Responses. OECD Studies on Water","author":"Organisation for Economic Co-operation and Development","year":"2019"},{"key":"2025072423370856900_CIT0048","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.watres.2017.09.019","article-title":"Negative environmental impacts of antibiotic-contaminated effluents from pharmaceutical industries","volume":"126","author":"Bielen","year":"2017","journal-title":"Water Res"},{"key":"2025072423370856900_CIT0049","doi-asserted-by":"publisher","first-page":"180","DOI":"10.3390\/microorganisms7060180","article-title":"Antibiotic pollution in the environment: from microbial ecology to public policy","volume":"7","author":"Kraemer","year":"2019","journal-title":"Microorganisms"},{"key":"2025072423370856900_CIT0050","doi-asserted-by":"publisher","first-page":"791","DOI":"10.5498\/wjp.v11.i10.791","article-title":"Environmental pollution with psychiatric drugs","volume":"11","author":"Argaluza","year":"2021","journal-title":"World J Psychiatry."},{"key":"2025072423370856900_CIT0051","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.chroma.2004.04.005","article-title":"Determination of pharmaceutical compounds in surface- and ground-water samples by solid-phase extraction and high-performance liquid chromatography-electrospray ionization mass spectrometry","volume":"1041","author":"Cahill","year":"2004","journal-title":"J Chromatogr A"},{"key":"2025072423370856900_CIT0052","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.scitotenv.2014.06.013","article-title":"Eco-directed sustainable prescribing: feasibility for reducing water contamination by drugs","volume":"493","author":"Daughton","year":"2014","journal-title":"Sci Total Environ"},{"key":"2025072423370856900_CIT0053","doi-asserted-by":"publisher","first-page":"130818","DOI":"10.1016\/j.jhazmat.2023.130818","article-title":"Anticancer drugs in wastewater and natural environments: a review on their occurrence, environmental persistence, treatment, and ecological risks","volume":"447","author":"Castellano-Hinojosa","year":"2023","journal-title":"J Hazard Mater"},{"key":"2025072423370856900_CIT0054","doi-asserted-by":"publisher","first-page":"371","DOI":"10.2165\/00002018-200629050-00001","article-title":"Ecopharmacology: a new topic of importance in pharmacovigilance","volume":"29","author":"K\u00fcmmerer","year":"2006","journal-title":"Drug Saf"},{"key":"2025072423370856900_CIT0055","doi-asserted-by":"publisher","first-page":"10406","DOI":"10.1021\/acs.est.5b01968","article-title":"Long-term persistence of an anxiolytic drug (oxazepam) in a large freshwater lake","volume":"49","author":"Klaminder","year":"2015","journal-title":"Environ Sci Technol"},{"key":"2025072423370856900_CIT0056","doi-asserted-by":"publisher","first-page":"6013","DOI":"10.1016\/j.watres.2012.08.025","article-title":"Occurrence and distribution of psychoactive compounds and their metabolites in the urban water cycle of Berlin (Germany)","volume":"46","author":"Hass","year":"2012","journal-title":"Water Res"},{"key":"2025072423370856900_CIT0057","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s10912-022-09774-x","article-title":"Pharmaceuticals in the water: The need for environmental bioethics","volume":"44","author":"Milovac","year":"2023","journal-title":"J Med Humanit"},{"key":"2025072423370856900_CIT0058","author":"British Medical Association","year":"2020"},{"key":"2025072423370856900_CIT0059","doi-asserted-by":"publisher","first-page":"100079","DOI":"10.1016\/j.joclim.2021.100079","article-title":"Interventions to reduce the environmental impact of medicines: A UK perspective","volume":"4","author":"Cussans","year":"2021","journal-title":"J. Clim. Change Health"},{"key":"2025072423370856900_CIT0060","doi-asserted-by":"publisher","first-page":"3918","DOI":"10.1111\/bcp.15311","article-title":"Environmental risk of pharmaceuticals: Let us look at the whole package","volume":"88","author":"Lertxundi","year":"2022","journal-title":"Br J Clin Pharmacol"}],"container-title":["International Journal of Pharmacy Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ijpp\/article-pdf\/33\/4\/360\/63412326\/riaf038.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ijpp\/article-pdf\/33\/4\/360\/63412326\/riaf038.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T03:37:14Z","timestamp":1753414634000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ijpp\/article\/33\/4\/360\/8154562"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,31]]},"references-count":60,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,5,31]]},"published-print":{"date-parts":[[2025,7,24]]}},"URL":"https:\/\/doi.org\/10.1093\/ijpp\/riaf038","relation":{},"ISSN":["0961-7671","2042-7174"],"issn-type":[{"value":"0961-7671","type":"print"},{"value":"2042-7174","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,8]]},"published":{"date-parts":[[2025,5,31]]}}}